Matthew S Thiese
Overview
Explore the profile of Matthew S Thiese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
2309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saullo R, Jones J, Thiese M, Cox C, Ogbonnaya U, Hegmann K
J Emerg Manag
. 2025 Jan;
22(6):639-648.
PMID: 39776368
Background: To determine the impacts of statewide coronavirus disease 2019 (COVID-19)-related public health and social measures (PHSMs) and attempted pandemic mitigation measures on years of potential life lost (YPLL). Methods:...
2.
Mak J, Khan S, Britton A, Rose S, Gwynn L, Ellingson K, et al.
J Infect Dis
. 2024 Nov;
PMID: 39531735
Background: While there is evidence that COVID-19 vaccination protects against development of post-COVID conditions (PCC) after severe infection data are limited on whether vaccination reduces the risk after cases of...
3.
Grant L, Whitaker J, Yoon S, Lutrick K, Bhargava S, Brown C, et al.
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae559.
PMID: 39416990
Background: Immunogenicity studies suggest that recombinant influenza vaccine (RIV) may provide better protection against influenza than standard-dose inactivated influenza vaccines (SD IIV). This randomized trial evaluated the relative vaccine effectiveness...
4.
Porter C, Lyski Z, Uhrlaub J, Ellingson K, Jeddy Z, Gwynn L, et al.
Diseases
. 2024 Aug;
12(8).
PMID: 39195170
Methods: A longitudinal cohort study of children aged ≥ 5 was conducted during August 2021-August 2022, at sites in Arizona, Texas, Utah, and Florida. Children submitted weekly nasal swabs for...
5.
Melhorn J, Gelinas B, Martin D, Hegmann K, Thiese M
J Occup Environ Med
. 2024 Jul;
66(10):834-838.
PMID: 39016248
Objectives: The aims of the study are to evaluate how upper limb impairment ratings are affected by updates to the AMA Guides to the Evaluation of Permanent Impairment (AMA Guides)...
6.
Melhorn J, Gelinas B, Martin D, Hegmann K, Thiese M
J Occup Environ Med
. 2024 May;
66(9):737-742.
PMID: 38729185
Objective: Describe and evaluate methodological improvements in AMA Guides to the Evaluation of Permanent Impairment ( Guides ) Sixth Edition 2024, including an updated sequential method and enhanced diagnosis-based impairment...
7.
Apostolopoulos Y, Sonmez S, Thiese M, Olufemi M, Gallos L
Am J Ind Med
. 2024 May;
67(6):515-531.
PMID: 38689533
Excess health and safety risks of commercial drivers are largely determined by, embedded in, or operate as complex, dynamic, and randomly determined systems with interacting parts. Yet, prevailing epidemiology is...
8.
Apostolopoulos Y, Sonmez S, Thiese M, Gallos L
Scand J Work Environ Health
. 2023 Nov;
50(2):83-95.
PMID: 37952240
Objectives: The thesis of this paper is that health and safety challenges of working people can only be fully understood by examining them as wholes with interacting parts. This paper...
9.
Hollister J, Caban-Martinez A, Ellingson K, Beitel S, Fowlkes A, Lutrick K, et al.
Environ Res
. 2023 Oct;
239(Pt 1):117297.
PMID: 37816422
Per- and polyfluoroalkyl substances (PFAS) are ubiquitous throughout the United States. Previous studies have shown PFAS exposure to be associated with a reduced immune response. However, the relationship between serum...
10.
Hegmann K, Thiese M, Wood E, Kapellusch J, Foster J, Drury D, et al.
J Occup Environ Med
. 2023 Jun;
65(8):e527-e533.
PMID: 37264528
Objective: The aim of the study is to assess risk of common musculoskeletal disorders (MSDs) based on cardiovascular disease (CVD) risk scores. Methods: Data from a 9-year prospective cohort of...